We have previously observed that depletion of the cell adhesion receptor JAM-A in tumor cells results in a loss of CIL associated with high Rac1 activity at sites of cell-cell contacts between colliding cells (Kummer et al., 2022). The gene discussed is RAC1; the disease is neoplasm.